Skip to content
  • KOSPI 2676.63 -7.02 -0.26%
  • KOSDAQ 865.59 -1.89 -0.22%
  • KOSPI200 363.58 -0.73 -0.20%
  • USD/KRW 1359 -12 -0.88%
  • JPY100/KRW 888.76 -4.55 -0.51%
  • EUR/KRW 1462.96 -7.78 -0.53%
  • CNH/KRW 188.98 -1.3 -0.68%
View Market Snapshot

Deals

Chemical Industry

Solvay named preferred bidder to buy Solus Biotech

Belgian chemicals maker Solvay S.A. has been selected as the preferred bidder to acquire South Korean biomaterials maker Solus Biotech, according to investment banking sources on Dec. 28.If clinched, the deal is expected to be valued at about 350 b

Dec 29, 2022 (Gmt+09:00)

1 Min read